Tag: #randomized trial

$#VisualAbstract: Ruxolitinib improved glucocorticoid-refractory chronic graft-versus-host disease$

#VisualAbstract: Ruxolitinib improved glucocorticoid-refractory chronic graft-versus-host disease

byMinjee Kim

August 25, 2021

1. Ruxolitinib was shown to significantly improve failure-free survival for glucocorticoid-refractory chronic graft-versus-host disease (GVHD) compared to control therapy. 2. ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result